AIM ImmunoTech Inc (AIM)
0.443
0.00 (0.00%)
USD |
NYAM |
Mar 27, 16:00
0.443
0.00 (0.00%)
After-Hours: 07:48
AIM ImmunoTech Enterprise Value: -0.1041M for March 27, 2024
Enterprise Value Chart
Historical Enterprise Value Data
Date | Value |
---|---|
March 27, 2024 | -0.1041M |
March 26, 2024 | -0.2995M |
March 25, 2024 | -0.2507M |
March 22, 2024 | -0.0699M |
March 21, 2024 | -3.132M |
March 20, 2024 | -2.199M |
March 19, 2024 | -1.960M |
March 18, 2024 | -3.425M |
March 15, 2024 | -5.623M |
March 14, 2024 | -5.452M |
March 13, 2024 | -4.158M |
March 12, 2024 | -4.402M |
March 11, 2024 | -4.158M |
March 08, 2024 | -3.279M |
March 07, 2024 | -2.986M |
March 06, 2024 | -2.717M |
March 05, 2024 | -2.448M |
March 04, 2024 | -2.448M |
March 01, 2024 | -2.175M |
February 29, 2024 | -2.156M |
February 28, 2024 | -2.156M |
February 27, 2024 | -1.711M |
February 26, 2024 | -1.716M |
February 23, 2024 | -1.345M |
February 22, 2024 | -1.960M |
Date | Value |
---|---|
February 21, 2024 | -1.472M |
February 20, 2024 | -1.228M |
February 16, 2024 | -3.23M |
February 15, 2024 | -2.693M |
February 14, 2024 | -1.892M |
February 13, 2024 | -2.204M |
February 12, 2024 | -0.9686M |
February 09, 2024 | -2.297M |
February 08, 2024 | -3.181M |
February 07, 2024 | -0.4949M |
February 06, 2024 | -0.3972M |
February 05, 2024 | -0.6512M |
February 02, 2024 | 0.1108M |
February 01, 2024 | -0.4949M |
January 31, 2024 | -1.472M |
January 30, 2024 | -0.7342M |
January 29, 2024 | -1.223M |
January 26, 2024 | -2.058M |
January 25, 2024 | -1.472M |
January 24, 2024 | -2.185M |
January 23, 2024 | -0.7391M |
January 22, 2024 | -1.301M |
January 19, 2024 | -1.223M |
January 18, 2024 | -0.7928M |
January 17, 2024 | -0.7391M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-21.35M
Minimum
Dec 29 2022
152.07M
Maximum
Mar 09 2020
17.90M
Average
5.411M
Median
Sep 03 2019
Enterprise Value Benchmarks
Standard BioTools Inc | 729.04M |
Perspective Therapeutics Inc | 320.44M |
Protalix BioTherapeutics Inc | 67.01M |
Electromed Inc | 130.78M |
Armata Pharmaceuticals Inc | 216.99M |
Enterprise Value Related Metrics
Net Income (Quarterly) | -7.816M |
Revenue (Quarterly) | 0.046M |
Total Expenses (Quarterly) | 8.203M |
EPS Diluted (Quarterly) | -0.16 |
Gross Profit Margin (Quarterly) | 34.78% |
Profit Margin (Quarterly) | -16.99K% |
Earnings Yield | -97.07% |
Normalized Earnings Yield | -96.65 |